Organogenesis Holdings Inc

Small-Cap Stocks Penny Stocks Biotech Stocks Healthcare Stocks

$2.40

-0.03 (-1.23%)

As of Jun 23, 3:06 PM ET ·

Analyst Consensus

Strong Sell

Analysts

Moderate

Coverage

Buy 0 0%

Hold 4 57%

Sell 3 43%

Price Target

Analyst Price Target +247.9% upside

Low Target $5.30

Average Target $8.35

High Target $10.56

Current Price $2.40

Current
$2.40

Target
$8.35

$5.30 $8.35 avg $10.56

Scenario Analysis

Bear Case

$5.30

120.8%

Low target

Base Case

$8.35

+247.9%

Avg target

Bull Case

$10.56

+340.0%

High target

Risk/Reward

2.8x

Favorable

Price in Context

52-Week High

$7.08

-66.1% from high

52-Week Low

$2.04

+17.6% from low

Target vs 52W High

$8.35

+18.0% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+9.7%
AMGN Amgen Inc	Hold	44	50%	$190.87	-45.0%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+190.0%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-6.4%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.6%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-64.5%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-32.7%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-39.1%